Your session is about to expire
← Back to Search
Online Cancer Screening & HPV Vaccination Strategy for Cervical Cancer Prevention
N/A
Waitlist Available
Led By Lara Savas, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-month follow up
Awards & highlights
Summary
This trial will develop and test an online strategy to help increase breast and cervical cancer screening and HPV vaccination rates for Latinas.
Who is the study for?
This trial is for Latinas aged 21-65 who haven't had a Pap test in the last 3 years, those aged 50-75 without a mammogram in the past 2 years, and those aged 21-26 who haven't started HPV vaccination. Participants must intend to use SEMM and be served by clinics with LHWs that cater to Latina populations in Texas.
What is being tested?
The study is testing 'Salud en Mis Manos' (SEMM), an internet platform designed to improve breast/cervical cancer screening and HPV vaccination among Latinas. It compares usual implementation practices against SEMM with extra support strategies.
What are the potential side effects?
Since this trial focuses on implementing a screening and vaccination program rather than testing new medications, it does not have typical medication side effects. However, there may be discomfort or other minor effects from the screening procedures or vaccinations.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8-month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-month follow up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Effectiveness (for HPV vaccination) as measured by the percentage of female patients who initiate or complete an HPV vaccination among all eligible patients.
Effectiveness (for screening) as measured by the percentage of women who complete cervical cancer screening (Pap or HPV screening test) among all eligible patients.
Effectiveness (for screening) as measured by the percentage of women who complete mammogram screening among all eligible patients.
+8 moreSecondary study objectives
Cost effectiveness of SEMM-DIA in community and clinic practice settings
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Salud en Mis Manos - Dissemination and Implementation AssistanceExperimental Treatment1 Intervention
The multi-component and multi-faceted implementation strategy SEMM-DIA
Group II: Salud en Mis Manos - Usual Implementation PracticeActive Control1 Intervention
The SEMM-Usual Implementation Practice arm includes all existing SEMM program materials.
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
934 Previous Clinical Trials
331,808 Total Patients Enrolled
2 Trials studying Cancer Prevention
2,054 Patients Enrolled for Cancer Prevention
Centers for Disease Control and PreventionFED
882 Previous Clinical Trials
22,472,985 Total Patients Enrolled
Lara Savas, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
3 Previous Clinical Trials
16,770 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Women of Latin or Hispanic descent who identify themselves as such are eligible to participate.I am a Latina woman aged 18-26 and have not started the HPV vaccine.I am a Latina woman, aged 21-64, and haven't had a Pap test in over 3 years.I am a Latina with a cancer diagnosis, affected by changes in cancer screening guidelines.I am a Latina woman aged 51-74 and haven't had a mammogram in over 2 years.I am a Latina woman, aged 30-64, and haven't had an HPV test in over 5 years.If you are a Latina woman and have not received recommended tests or screenings for breast or cervical cancer prevention according to US guidelines.You are willing to participate in SEMM implementation.
Research Study Groups:
This trial has the following groups:- Group 1: Salud en Mis Manos - Dissemination and Implementation Assistance
- Group 2: Salud en Mis Manos - Usual Implementation Practice
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger